Literature DB >> 3467129

Gangliosides of human melanoma.

T Tsuchida, R E Saxton, D L Morton, R F Irie.   

Abstract

The ganglioside composition of human malignant melanoma was studied with the use of 80 melanoma specimens, including 52 surgical specimens and 28 cultured cell lines. A ganglioside fraction was isolated and purified from each of these tissues, and the amount of each component ganglioside was assessed by thin-layer chromatography (TLC) and a TLC scanner. Five gangliosides (GM3, GD3, GM2, GD2, and alkali-labile ganglioside) were most commonly expressed by these melanomas. However, the total ganglioside amount (ranging from 33 to 302 micrograms/g wet wt of tissue) as well as the distribution of each ganglioside were widely heterogeneous in both biopsied and cultured melanomas. When the ganglioside expressions of cultured and biopsied melanomas were compared, GM2 and GD2 were minor components of biopsied melanomas but often became major components of cultured melanoma cells. Conversely, alkali-labile ganglioside was expressed more strongly on biopsied melanomas. This heterogeneity suggests that it will be necessary to analyze the ganglioside composition of biopsied melanomas before using monoclonal antibodies to melanoma-associated gangliosides for melanoma diagnosis or therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3467129     DOI: 10.1093/jnci/78.1.45

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  37 in total

1.  Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside function.

Authors:  Lixian Dong; Yihui Liu; Anamaris M Colberg-Poley; Karen Kaucic; Stephan Ladisch
Journal:  Glycoconj J       Date:  2011-04-26       Impact factor: 2.916

2.  Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.

Authors:  Lei Qiu; Xi Gong; Qianli Wang; Jie Li; Honggang Hu; Qiuye Wu; Junping Zhang; Zhongwu Guo
Journal:  Cancer Immunol Immunother       Date:  2012-04-27       Impact factor: 6.968

3.  Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse.

Authors:  Qianli Wang; Zhifang Zhou; Shouchu Tang; Zhongwu Guo
Journal:  ACS Chem Biol       Date:  2011-11-01       Impact factor: 5.100

4.  Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.

Authors:  Kazuo Koyanagi; Christine Kuo; Taku Nakagawa; Takuji Mori; Hideaki Ueno; Arnulfo R Lorico; He-Jing Wang; Eddie Hseuh; Steven J O'Day; Dave S B Hoon
Journal:  Clin Chem       Date:  2005-04-07       Impact factor: 8.327

Review 5.  Anti-GD2 antibody therapy for GD2-expressing tumors.

Authors:  Fariba Navid; Victor M Santana; Raymond C Barfield
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

6.  Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates.

Authors:  Shichong Yu; Qianli Wang; Junping Zhang; Qiuye Wu; Zhongwu Guo
Journal:  Medchemcomm       Date:  2011-01-01       Impact factor: 3.597

7.  Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.

Authors:  Gianni Gerlini; Adrian Tun-Kyi; Christa Dudli; Günter Burg; Nicola Pimpinelli; Frank O Nestle
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

Authors:  K Kitamura; P O Livingston; S R Fortunato; E Stockert; F Helling; G Ritter; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Cellular immuno-PCR. Detection of a carbohydrate tumor marker.

Authors:  Z Zhang; R F Irie; D D Chi; D S Hoon
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  Monoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells.

Authors:  K Ding; T Ekberg; J Zeuthen; S Teneberg; K A Karlsson; A Rosén
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.